Lisa Harding, MD, urges psychiatrists to gather histories, deprescribe safely, and send focused sleep referrals now that orexin agonists have arrived for narcolepsy.
|Poll|November 2, 2018
Mini Quiz: Measuring Sleep Quality in Patients With ADHD
Author(s)Margaret D. Weiss, MD, PhD
Which tool is useful to measure night-to-night variability, sleep onset latency, and sleep duration in those with ADHD?
Advertisement
Which of the following is a useful measure that can be used to visually display night-to-night variability, sleep onset latency, and sleep duration in those with ADHD?
Advertisement
Related to this article
Don't miss out on these CME articles! Test your knowledge here.
Early trial shows investigational orexin-2 agonist ALKS 7290 improves adult ADHD symptoms in 14 days, with tolerable safety, paving way for phase 2.
Phase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.
Advertisement
Advertisement
Trending on Psychiatric Times
1
What Clinicians Need to Know About Postpartum Psychosis
2
Nature vs Nurture: The Interplay Between Genetics and Environmental Influences
3
AI as a Task-Replacing Tool for Psychiatric Care: A Conversation With Christoph Correll, MD
4
Brain Trust: Therapeutic Drug Monitoring and Adherence in Schizophrenia, With Jonathan M. Meyer, MD
5